🍁Vermont State AGlinked via multistate filing link · 100%
Clustered 4 filings across 4 jurisdictions · filed Dec 4, 2024. View entity profile → Other incidents for this victim →
incident inc_744d83c488044436 · merge_method deterministic · confidence 100%
Discovered → first regulatory filing
Range of discovered_at dates across filings
CA MT OR VT
Time between earliest and latest filing
Not recorded for this incident
Leak precedence · Materiality delta · SEC filing delay — no leak-site claim in this cluster; no SEC 8-K in this cluster.
all State AG
Earliest sighting first · deep chronology in Litigation Timeline
Oct 24, 2024 → Nov 4, 2024
When the intrusion reportedly occurred, per the linked filings
Nov 4, 2024
Reported by VERMONT AG, CALIFORNIA AG filings
About this clustering
DisclosureLens links filings into incidents through layered matchers: deterministic rules (same source document, multistate filings of one breach, tight-window same-victim pairs), a weighted-similarity scorer for cross-source candidates, and an operator review queue for everything uncertain. Each link records its own method and confidence — shown per filing in the timeline below. The system defaults to NOT merging when uncertain, because a false merge (collapsing two unrelated breaches) is more harmful than a false split (showing related filings separately); uncertain pairs route to human review instead of auto-merging. Filing summaries shown in the timeline are AI-generated extracts — verify each against its linked source.
Acadia Pharmaceuticals Inc. disclosed a data breach affecting its 'More to Parkinson’s' community. Due to an internal email misconfiguration, a recipient's registered name was sent to another member's email address. Only names were exposed; no medical records or other PII were accessed. The incident was discovered on November 4, 2024, and regulators were notified.
Acadia Pharmaceuticals Inc. experienced a data incident involving the misdelivery of emails to members of its 'More to Parkinson’s' community. Due to an internal error, emails sent between October 24 and November 4, 2024, contained recipient names that did not match the email addresses they were sent to, potentially disclosing the name of one individual to another. Acadia became aware of the incident on November 4, 2024. No medical records or other identifiable information beyond names were disclosed.
Acadia Pharmaceuticals Inc. reported a data breach to the Montana Attorney General. The breach was reported on 2024-12-04. The breach occurred from 10/24/2024 to 10/30/2024.
Acadia Pharmaceuticals Inc. reported a data breach to the Oregon Attorney General. The breach was reported on 2024-12-04. 14,065 individuals were affected.
Affected (this filing): 14,065